ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 123

Acupuncture for Pediatric Chronic Pain Relief: A Review

Yujuan Zhang1, Stephanie Hyon2 and Chenchen Wang3, 1Pediatric Rheumatology, Tufts Medical Center, Boston, MA, 2Rheumatology, Tufts Medical School, Boston, MA, 3Rheumatology, Tufts Medical Center, Boston, MA

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: acupuncture and pediatrics, Chronic pain

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: Acupuncture, a type of complementary and integrative therapy, has been widely used for pain relief in adults. However, evidence of the effect of acupuncture for pediatric chronic pain is scarce. We evaluate the effect of acupuncture on chronic pain in pediatric population.

Methods: We performed a comprehensive search of eastern and western databases in MEDLINE and Chinese databases: China Hospital Knowledge Database, China National Knowledge infrastructure, WanFang Data, and Traditional Chinese Medical Database System until January 2017. Selection criteria included clinical trials and observational studies of acupuncture in pediatric chronic pain patients, sample size ≥8, and outcome measures included pain evaluation.

Results: We identified 142 potentially relevant studies. Eight studies (total 493 participants) met eligibility criteria. Of the 8 studies, 1 was randomized controlled trial, 5 were nonrandomized controlled trials, and 2 were retrospective chart reviews. Four used traditional Chinese acupuncture, 1 Korean hand acupuncture, 1 Japanese style needle, and the other 2 unclear. Table summarizes the studies evaluating the effect of acupuncture on pain. More than 90% of subjects were able to complete all treatments. Acupuncture was associated with a significant pain reduction in 7/8 studies. All 8 studies reported improvement in pain related function after treatments. Four of 8 studies showed a reduction in pain by 3 to 5 points on pain scale; 3/8 studies reported either a high percentage of improvement in pain (70~96%) or a statistically significant reduction on pain scale (1.5 point, P<0.001). One study reported that patients with chronic fatigue improved function (P<0.01). None of the studies reported any adverse effects related to the acupuncture treatment, with 7 studies clearly stating that there were no adverse effects from the acupuncture treatment. Discordant trial designs, varying outcome measures, and methodological limitations precluded a pooled meta-analysis.

Conclusion: The current evidence suggests that acupuncture appears to be safe and helpful treatment for chronic pain in the pediatric population, but is insufficient for a definitive conclusion. Rigorous and well-controlled randomized trials are warranted.

References

1. Pintov S, et al. Pediatr Neurol 1997; 17

2. Jodorkovsky R. Medical Acupuncture 1999

3. Kemper KJ, et al. Pediatrics 2000;105

4. Lin Y-C, et al. Medical Acupuncture 2002;14

5. Zeltzer LK, et al. J Pain Symptom Manage 2002;24

6. Lin Y, et al. Acupuncture in medicine 2004;(16)

7. Lin YC. ASA Annual Meeting. San Francisco (CA), Oct 2007

8. McDonald MJ. Medical Acupuncture 2015; 27

 

          

 Table

Reference

Study Design

age (yr)

N

Indications

Intervention(s) and doses

                 Results

Author’s Conclusions on Acupuncture

[1]

Pintov, 1997

 Israel

Randomized Controlled Trial

 

7-15

22

Migraine headaches

1) TCA1

2) needle in stratum corneum for

placebo acupuncture group

Weekly for 10 weeks

(1) Frequency of Headache reduced 9.3à1.4 in TCA1

(2) VAS2 reduced 8.7à3.3 in TCA1

(3) Panopioid activity inhibition and Beta-endorphinlike immunoreactivity showed changes consistent with effective pain reduction in TCA1

Safe, efficient for migraine headaches in children

[2]

Jodorkovsky, 1999

USA

Nonrandomized controlled studies

3.5-20

106

1. Traumatic pain

2. Musculoskeletal pain (10% chronic)

3. Non-painful conditions

Korean Hand Acupuncture, 1-4+ treatments per subject over 6 months

(1) Pain scale (1 to 10); 96% complete resolution or decrease pain by >50%,

(2) >50% decrease in duration of symptoms in non-painful conditions

Safe, cost-effective and well accepted in children

[3]

Kemper, 2000

USA

Retrospective case series

5-20

47

1. Migraine headaches

2. Endometriosis

3. Reflex sympathetic dystrophy

1) regular needle 98%

2) Moxibustion/heat 85%

3) Cupping 26%, Magnets 26%

Median of 8 treatments over 3 months per subject

(1) 67% of patients (60% of parents) reported the treatments pleasant or relaxing; (2) 70% of patients ( 59% of parents) reported the treatments helpful

Pleasant and helpful in children with chronic pain

[4]

Lin, 2002

USA

Nonrandomized controlled studies

2-18

53

1. limb pain 24%

2. Abd pain 24%

3. back pain 17%

4. Headaches 15%

TCA1; 112 treatments in 53 subjects

VAS2 reduced by a mean of 3.1 points (P<0.01, average effect duration 3 days)

 

Reduced pain in pediatric patients significantly

[5]

Zeltzer, 2002

USA

Nonrandomized controlled studies

6-18

33

1. Migraine headaches 46%

2. Abd pain 21%

3. Fibromyalgia 11%

4. CRPS3 11%

5. JRA4 4%

TCA1 with a 20-minute hypnosis session, weekly for 6 weeks

(1) VAS2 reduced 3.46à1.93 (P<0.001)

(2) Total interference5 reduced 30.48à23.13 (P=0.014)

 

Acupuncture is feasible  with evidence of pain reduction in pediatrics

[6]

Lin, 2004

USA

Nonrandomized controlled studies

11-18

8

Chronic fatigue and pain

Not otherwise specified, at 9 acupuncture points weekly for 6 weeks

(1) VAS2 6.5à5.8 (P>0.5)

(2) Function level (0-10) improved 4.5à7.0 (P<0.01)

Improved functional level in patients with chronic fatigue syndrome

[7]

Lin, 2002

USA

Nonrandomized controlled studies

9-18

50

Headaches

TCA1, weekly for 6 weeks, elective bi-monthly treatment afterwards, mean of 6 treatment per subject

VAS2 reduced 7.4à4.1 (P<0.01)

 

Well tolerated and beneficial treatment for pediatric headaches

[8]

McDonald, 2015

USA

Retrospective chart review

0-21

174

1. Headaches 48%

2. back pain 28%

3. Neck, extremity pain 27%

4. Fibromyalgia 9%

5. Abd pain 9%

6. CRPS3 7%

1) Japanese style needle 96%

2) electroacupuncture 90%

3) Laser therapy 49%

4) Auricular acupuncture 32%

1090 treatment for 174 subjects over 3 years

VAS2 reduced 5.5à2.2 (P<0.001)

Well tolerated, safe and effective for pediatric pain management

1. TCA: traditional Chinese style acupuncture 2. VAS: Visual analogue scale 3. CRPS: Complex Regional Pain Syndrome 4. JRA: Juvenile rheumatoid arthritis 5. Total interference: ratings of total pain-related interference in functioning


Disclosure: Y. Zhang, None; S. Hyon, None; C. Wang, None.

To cite this abstract in AMA style:

Zhang Y, Hyon S, Wang C. Acupuncture for Pediatric Chronic Pain Relief: A Review [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/acupuncture-for-pediatric-chronic-pain-relief-a-review/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/acupuncture-for-pediatric-chronic-pain-relief-a-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology